Doubling of serum creatinine in clinical trials, cost-effectiveness studies, and individual patients: Adequate use in renal transplantation

Transplantation

Volumn 92, Issue 9, 2011, Pages 1012-1017

  Gatault, Philippe ^a,b   Al Najjar, Azmi ^a   Barbet, Christelle ^a   Roland, Mélanie ^a   Laouad, Inass ^a   Buchler, Matthias ^a,b   Marlière, Jean Frédéric ^a   Métais, Pierre Emmanuel ^a   Clément, Alice ^a   Nivet, Hubert ^a,b   Lebranchu, Yvon ^a,b   Halimi, Jean Michel ^a,b  

^a CHU BRETONNEAU   (France)

^b FHU SUPORT   (France)

Author keywords

Clinical trials; Cost effectiveness studies; Doubling of serum creatinine; Epidemiology; Renal transplantation; Surrogate endpoint

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGE; ARTICLE; BODY WEIGHT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DOUBLING OF SERUM CREATININE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HAZARD RATIO; HUMAN; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX;

ADULT; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 80054983517     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31823015e4     Document Type: Article

References (26)

1. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 2008; 358: 2560.
2. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547.
3. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Eng J Med 2001; 345: 861.
4. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851.
5. Rossing P. Doubling of serum creatinine: It is sensitive and relevant? Nephrol Dial Transplant 1998; 13: 244.
6. Palmer AJ, Annemans L, Rose S, et al. Cost-effectiveness of early irbesartan treatment vs control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease. Diabetes Care 2004; 27: 1897.
7. Rodby RA, Chiou CF, Borenstein J, et al. The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetes mellitus. Clin Ther 2003; 7: 2102.
8. Delea TE, Sofrygin O, Palmer JL, et al. Cost-effectiveness of aliskiren in type 2 diabetes mellitus. J Am Soc Nephrol 2009; 20: 2205.
9. Fellstrom B, Holdaas H, Jardine AG, et al. Risk factors for reaching renal endpoints in the assessment of lescol in renal transplantation (ALERT) trial. Transplantation 2005; 79: 205.
10. Knoll GA, Cantarovitch M, Cole E, et al. The Canadian ACE-inhibitor trial to improve renal outcomes and patients survival in kidney transplantation. Nephrol Dial Transplant 2008; 23: 354.
11. Blach A, Franek E, Witula A, et al. The influence of chronic periodontitis on serum TNF-alpha, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients. Clin Transplant 2009; 23: 213.
12. Yuen SK, Mak YF, Tang HL, et al. Renal allograft C4d deposition in Chinese: Hong Kong perspective. Nephrology 2008; 13: 256.
13. Chow KM, Szeto CC, Leung CB, et al. Body mass index as a predictive factor for long-term renal transplant outcomes in Asians. Clin Transplant 2006; 20: 582.
14. Canales M, Youssef P, Spong R, et al. Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation. Am J Transplant 2006; 6: 2157.
15. Jafar TH, Schmid CH, Stark PC, et al. The rate of progression of renal disease may not be slower in women compared with men: A patientlevel meta-analysis. Nephrol Dial Transplant 2003; 18: 2047.
16. Coggins C, Breyer Lewis J, Caggiula AW, et al. Differences between women and men with chronic renal disease. Nephrol Dial Transplant 1998; 13: 1430.
17. Ruggenenti P, Perna A, Zoccali C, et al. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: Differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J Am Soc Nephrol 2000; 11: 88.
18. Li PK, Ho KK, Szeto CC, et al. Prognostic indicators of IgA nephropathy in the Chinese-Clinical and pathological perspectives. Nephrol Dial Transplant 2002; 17: 64.
19. Gerth WC, Remuzzi G, Viberti G, et al. Losartan reduces the burden and cost of ESRD: Public health implications from the RENAAL study for the European Union. Kidney Int Suppl 2002; 62: S68.
20. Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006; 354: 131.
21. Austin HA III, Boumpas DT, Vaughan EM, et al. Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int 1994; 45: 544.
22. Jacobi J, Rockstroh J, John S, et al. Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation 2000; 70: 819.
23. Halimi JM, Laouad I, Buchler M, et al. Early low-grade proteinuria: Causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005; 5: 2281.
24. Laouad I, Halimi JM, Buchler M, et al. Recipient age and mycophenolate mofetil as the main determinants of outcome after steroid withdrawal: Analysis of long-term follow-up in renal transplantation. Transplantation 2005; 80: 872.
25. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.
26. Halimi JM, Buchler M, Al-Najjar A, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant 2007; 7: 618.